Ohtani stays in the lineup while the Dodgers pause the mound

Shohei Ohtani will keep hitting for the Los Angeles Dodgers. He will not, for now, keep pitching. Manager Dave Roberts said Sunday that Ohtani is scratched from Wednesday’s scheduled start against the Philadelphia Phillies and will stay off the mound for “some time” while the club manages irritation in his left knee. Roberts was clear that the pause is not a day-to-day scratch. He was also clear that the Dodgers still expect Ohtani to pitch again this season.

The knee first flared on June 11 in Pittsburgh, when Ohtani left a game early with inflammation. He missed one lineup the next day, returned as a hitter, and kept making his pitching turns until the club scratched his July 10 start. During the All-Star break he received an Orthovisc injection — a lubricant shot rather than the fluid drain that had been discussed earlier — and skipped the Midsummer Classic in Philadelphia. The hope was that rest plus the injection would settle the joint enough for a Wednesday return against the Phillies.

That plan ended after Ohtani played catch over the Yankees weekend and told the training staff the knee was not progressing as expected. The Dodgers never put him on a bullpen mound to test it. “Where we’re at right now, how we’re proceeding, I would say that it’s going to be some time,” Roberts said before Sunday’s doubleheader in New York. “I’d say that it’s not going to be a day-to-day thing.” Emmet Sheehan’s next start was shifted to Monday in Philadelphia so the rotation could keep moving without Ohtani.

The mechanical detail matters because it explains the split workload. The left knee is Ohtani’s back leg when he hits and his landing leg when he pitches. Roberts said the torque of driving off that land leg is what aggravates the irritation; swinging does not produce the same sensation. That is why the Dodgers have not considered shutting him down as a hitter. Ohtani went 2-for-5 with two RBIs in the first game of Sunday’s Yankees doubleheader and remained in the leadoff designated-hitter spot for the nightcap.

The production around the injury still looks like an MVP case on both sides of the ball. Through mid-July, Ohtani was about .290 with 22 home runs as a hitter and 8–2 with a 1.79 ERA over 85⅔ innings as a pitcher, with 95 strikeouts. He has not pitched since July 3, when he threw a season-high 110 pitches over six innings against San Diego. The mound version of his season is paused at a high water mark; the bat version is continuing in real time.

Los Angeles can afford the patience because of the standings as much as the medical report. The Dodgers entered that Yankees series with the best record in the majors and a double-digit lead in the National League West. Blake Snell is working back from elbow issues on a Triple-A rehab track; Tyler Glasnow is progressing toward a return; Yoshinobu Yamamoto, Sheehan, and the rest of the staff can cover starts while Ohtani heals. Roberts framed the choice bluntly: Ohtani could probably pitch through it, but the benefits do not outweigh the cost with October still the priority.

That priority connects to the longer Ohtani story the Dodgers have been managing all summer. After his 300th career home run on July 7, Roberts talked about 500 as a distant possibility and about knee care as the nearer task. The Orthovisc shot and the indefinite pitching pause are the next chapter of that same management problem: how to keep the most valuable two-way player in baseball available for October without pretending the knee irritation is gone.

For now the roster card is simpler than the timeline. Ohtani remains the Dodgers’ designated hitter. The rotation moves forward without him. Roberts says he will pitch again this year and declines to say when. The two-way experiment is not over. One half of it is waiting on a knee that only complains when he lands on the mound.